Date Title Description PDF
12 Apr 2021 On business and financial situation The Company releases the press release related to its participation in the manufacture of the active substance of Moderna’s COVID-19 vaccine. Download
02 Mar 2021 On business and financial situation The Company releases an update of the regulatory processes of its long-acting injectable antipsychotic, Doria®, both in Europe and the United States  Download
02 Mar 2021 On business and financial situation The Company releases a presentation related to an update of the regulatory processes of its long-acting injectable antipsychotic, Doria®, both in Europe and the United States  Download
24 Feb 2021 About corporate governance The Company informs about the agreements adopted by the Board of Directors  Download
27 Nov 2020 On business and financial situation The Company publishes the results of the PRISMA-3 study of the efficacy and safety of Doria® in schizophrenic patients in the journal npj Schizophrenia Download

Pages

Date Title Description PDF
26 Jun 2023 Other relevant information The Company informs about the dividends payment Download
14 Jun 2023 Announcement of general shareholders’ meeting ROVI releases the information related to its General Shareholders Meeting. Download
31 May 2023 Other relevant information ROVI informs about the news items that have appeared in several media today regarding ROVI’s receipt of government grants Download
10 May 2023 Announcement of General Shareholders’ Meeting ROVI releases the information related to its General Shareholders Meeting Download
10 Apr 2023 Liquidity and counterparty agreements Liquidity contract: transactions conducted in the first quarter of 2023 Download

Pages

Date Title Description PDF
08 Nov 2012 Composición Consejo de Administración Download
18 Sep 2012 Otros sobre negocio y situación financiera Download
26 Jul 2012 Información sobre resultados (2) Download
26 Jul 2012 Información sobre resultados Download
26 Jul 2012 Información financiera intermedia Download

Pages